Panacea in talks with Bharat Biotech to make Covaxin

Panacea Biotech and Bharat Biotech are in talks for making Covaxin vaccine at the former’s New Delhi facility as the Hyderabad-based company looks at contract manufacturing options to expand its capacity amidst growing demand for Covid-19 jabs. Discussions are at an early stage and could be conditional on the government agreeing to provide easy financing for the new production line, an official aware of the development told ET. If the funding